UK markets open in 5 hours 42 minutes
NIKKEI 225
37,977.16 -482.92 (-1.26%) HANG SENG
17,201.27 +372.34 (+2.21%) CRUDE OIL
82.69 -0.12 (-0.14%) GOLD FUTURES
2,330.20 -8.20 (-0.35%) DOW
38,460.92 -42.77 (-0.11%) Bitcoin GBP
51,719.25 -1,836.77 (-3.43%)
Evelo Biosciences, Inc. (EVLO)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 12:09PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 806.77k |
| Enterprise value | 17.49M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 3.51 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -0.24 |
Trading information
Stock price history
| Beta (5Y monthly) | 2.03 |
| 52-week change 3 | -97.85% |
| S&P500 52-week change 3 | 25.01% |
| 52-week high 3 | 13.9300 |
| 52-week low 3 | 0.0280 |
| 50-day moving average 3 | 0.0509 |
| 200-day moving average 3 | 2.3965 |
Share statistics
| Avg vol (3-month) 3 | 37.99k |
| Avg vol (10-day) 3 | 15.89k |
| Shares outstanding 5 | 18.98M |
| Implied shares outstanding 6 | 18.98M |
| Float 8 | 16.69M |
| % held by insiders 1 | 0.14% |
| % held by institutions 1 | 13.16% |
| Shares short (30 Nov 2023) 4 | 196.99k |
| Short ratio (30 Nov 2023) 4 | 0.12 |
| Short % of float (30 Nov 2023) 4 | 2.22% |
| Short % of shares outstanding (30 Nov 2023) 4 | 1.04% |
| Shares short (prior month 31 Oct 2023) 4 | 156.44k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:20 |
| Last split date 3 | 30 Jun 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2022 |
| Most-recent quarter (mrq) | 30 Sept 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -83.25% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -69.67M |
| Net income avi to common (ttm) | -82.35M |
| Diluted EPS (ttm) | -16.2700 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 17.26M |
| Total cash per share (mrq) | 0.91 |
| Total debt (mrq) | 33.95M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.48 |
| Book value per share (mrq) | -1.42 |
Cash flow statement
| Operating cash flow (ttm) | -73.7M |
| Levered free cash flow (ttm) | -43.31M |
© 2024 Yahoo. All rights reserved.